P. Argani, Primary Renal Neoplasms with the ASPL-TFE3 Gene Fusion of Alveolar Soft Part Sarcoma, The American Journal of Pathology, vol.159, issue.1, pp.179-92, 2001.
DOI : 10.1016/S0002-9440(10)61684-7

P. Argani and M. Ladanyi, Translocation Carcinomas of the Kidney, Clinics in Laboratory Medicine, vol.25, issue.2, pp.363-78, 2005.
DOI : 10.1016/j.cll.2005.01.008

P. Argani, Renal Carcinomas With the t(6;11)(p21;q12), The American Journal of Surgical Pathology, vol.29, issue.2, pp.230-270, 2005.
DOI : 10.1097/01.pas.0000146007.54092.37

P. Argani, Xp11 Translocation Renal Cell Carcinoma in Adults: Expanded Clinical, Pathologic, and Genetic Spectrum, The American Journal of Surgical Pathology, vol.31, issue.8, pp.1149-60, 2007.
DOI : 10.1097/PAS.0b013e318031ffff

G. Bardi, Trisomy 7 as the sole cytogenetic aberration in the epithelial component of a colonic adenoma, Cancer Genetics and Cytogenetics, vol.82, issue.1, pp.82-84, 1995.
DOI : 10.1016/0165-4608(95)00000-8

G. Belge, A characteristic sequence of trisomies starting with trisomy 7 in benign thyroid tumors, Human Genetics, vol.94, issue.2, pp.198-202, 1994.
DOI : 10.1007/BF00202871

T. Breitkreuz, Genotypic characterization of prostatic carcinomas: a combined cytogenetic, flow cytometry and in situ hybridization study, Cancer Res, vol.53, pp.4035-4040, 1993.

J. Brown, Fluorescence In Situ Hybridization Analysis of Renal Oncocytoma Reveals Frequent Loss of Chromosomes Y and 1, The Journal of Urology, vol.156, issue.1, pp.31-36, 1996.
DOI : 10.1016/S0022-5347(01)65929-9

J. Brown, Simultaneous chromosome 7 and 17 gain and sex chromosome loss provide evidence that renal metanephric adenoma is related to papillary renal cell carcinoma

M. Brunelli, Gains of Chromosomes 7, 17, 12, 16, and 20 and Loss of Y Occur Early in the Evolution of Papillary Renal Cell Neoplasia: A Fluorescent In Situ Hybridization Study, Modern Pathology, vol.16, issue.10, pp.1053-1062, 2003.
DOI : 10.1097/01.MP.0000090924.90762.94

M. Brunelli, Eosinophilic and classic chromophobe renal cell carcinomas have similar frequent losses of multiple chromosomes from among chromosomes 1, 2, 6, 10, and 17, and this pattern of genetic abnormality is not present in renal oncocytoma, Modern Pathology, vol.55, issue.2, pp.161-170, 2005.
DOI : 10.1002/(SICI)1096-9896(199801)184:1<58::AID-PATH987>3.3.CO;2-T

D. Chao, COLLECTING DUCT RENAL CELL CARCINOMA:, The Journal of Urology, vol.167, pp.71-75, 2002.
DOI : 10.1097/00005392-200201000-00018

W. Chow, Obesity, Hypertension, and the Risk of Kidney Cancer in Men, New England Journal of Medicine, vol.343, issue.18, pp.1305-1316, 2000.
DOI : 10.1056/NEJM200011023431804

C. Corless, Papillary Renal Cell Carcinoma, Diagnostic Molecular Pathology, vol.5, issue.1, pp.53-64, 1996.
DOI : 10.1097/00019606-199603000-00009

P. Dal-cin, Chromosome changes in sarcomatoid renal carcinomas are different from those in renal cell carcinomas, Cancer Genetics and Cytogenetics, vol.134, issue.1, pp.38-40, 2002.
DOI : 10.1016/S0165-4608(01)00615-X

E. Gammal and A. , Chromosome 8p Deletions and 8q Gains are Associated with Tumor Progression and Poor Prognosis in Prostate Cancer, Clinical Cancer Research, vol.16, issue.1, pp.56-64, 2010.
DOI : 10.1158/1078-0432.CCR-09-1423

L. Fuzesi, Collecting duct carcinoma: cytogenetic characterization, Histopathology, vol.49, issue.2, pp.155-160, 1992.
DOI : 10.1016/0165-4608(84)90028-1

L. Fuzesi, Losses of 1p and chromosome 14 in renal oncocytomas, Cancer Genetics and Cytogenetics, vol.160, issue.2, pp.120-125, 2005.
DOI : 10.1016/j.cancergencyto.2004.12.010

J. Garcia and B. Rini, Recent Progress in the Management of Advanced Renal Cell Carcinoma, CA: A Cancer Journal for Clinicians, vol.57, issue.2, pp.112-137, 2007.
DOI : 10.3322/canjclin.57.2.112

L. Glukhova, Overrepresentation of 7q31 and 17q in renal cell carcinomas, Genes, Chromosomes and Cancer, vol.77, issue.3, pp.171-179, 1998.
DOI : 10.1002/(SICI)1098-2264(199807)22:3<171::AID-GCC2>3.0.CO;2-T

B. Gunawan, Prognostic impacts of cytogenetic findings in clear cell renal cell carcinoma: Gain of 5q31-qter predicts a distinct clinical phenotype with favorable prognosis, Cancer Res, vol.61, pp.7731-7738, 2001.

P. Hadaczek, Losses at 3p common deletion sites in subtypes of kidney tumours: histopathological correlations, Virchows Archiv, vol.429, issue.1, pp.37-42, 1996.
DOI : 10.1007/BF00196818

C. Hill and F. Doyon, The frequency of cancer in France: mortality trends since 1950 and summary of the report on the causes of cancer], Bull Cancer, vol.95, issue.1, pp.5-10, 2008.

M. Hoglund, Dissecting karyotypic patterns in renal cell carcinoma: an analysis of the accumulated cytogenetic data, Cancer Genetics and Cytogenetics, vol.153, issue.1, pp.1-9, 2004.
DOI : 10.1016/j.cancergencyto.2003.12.019

O. Iliopoulos, Molecular Biology of Renal Cell Cancer and the Identification of Therapeutic Targets, Journal of Clinical Oncology, vol.24, issue.35, pp.5593-5600, 2006.
DOI : 10.1200/JCO.2006.08.8948

M. Jeffers, Activating mutations for the Met tyrosine kinase receptor in human cancer, Proceedings of the National Academy of Sciences, vol.94, issue.21, pp.11445-50, 1997.
DOI : 10.1073/pnas.94.21.11445

A. Jemal, Cancer Statistics, 2010, CA: A Cancer Journal for Clinicians, vol.60, issue.5, pp.277-300, 2010.
DOI : 10.3322/caac.20073

F. Jiang, Chromosomal Imbalances in Papillary Renal Cell Carcinoma, The American Journal of Pathology, vol.153, issue.5, pp.1467-73, 1998.
DOI : 10.1016/S0002-9440(10)65734-3

T. Jones, Clonal divergence and genetic heterogeneity in clear cell renal cell carcinomas with sarcomatoid transformation, Cancer, vol.55, issue.6, pp.1195-203, 2005.
DOI : 10.1002/cncr.21288

W. Kim and W. Kaelin, Molecular Pathways in Renal Cell Carcinoma???Rationale for Targeted Treatment, Seminars in Oncology, vol.33, issue.5, pp.588-95, 2006.
DOI : 10.1053/j.seminoncol.2006.06.001

T. Klatte, The von Hippel-Lindau tumor suppressor gene, Exp Cell Res, vol.264, pp.117-142, 2001.

T. Klatte, Understanding the natural biology of kidney cancer: Implications for targeted cancer therapy, Rev Urol, vol.9, pp.47-56, 2007.

T. Klatte, Cytogenetic Profile Predicts Prognosis of Patients With Clear Cell Renal Cell Carcinoma, Journal of Clinical Oncology, vol.27, issue.5, pp.746-53, 2009.
DOI : 10.1200/JCO.2007.15.8345

T. Klatte, Gain of chromosome 8q is associated with metastases and poor survival of patients with clear cell renal cell carcinoma. Cancer, pp.5777-82, 2012.

D. Knight and W. Stadler, Prognostic factors in localized renal cell cancer, BJU International, vol.19, issue.5b, pp.1212-1216, 2007.
DOI : 10.1097/00005392-200107000-00015

G. Kovacs and S. Frisch, Clonal chromosome abnormalities in tumor cells from patients with sporadic renal cell carcinomas, Cancer Res, vol.49, pp.651-660, 1989.

G. Kovacs, Papillary renal cell carcinoma. A morphologic and cytogenetic study of 11 cases, Am J Pathol, vol.134, pp.27-34, 1989.

G. Kovacs, Cytogenetics of papillary renal cell tumors, Genes, Chromosomes and Cancer, vol.327, issue.4, pp.249-55, 1991.
DOI : 10.1002/gcc.2870030403

G. Kovacs, Molecular Cytogenetics of Renal Cell Tumors, Cancer Res, vol.62, pp.89-124, 1993.
DOI : 10.1016/S0065-230X(08)60316-4

G. Kovacs, The Heidelberg classification of renal cell tumours, pp.13-16, 1997.

N. Kroeger, Deletions of chromosomes 3p and 14q molecularly subclassify clear cell renal cell carcinoma. Cancer, 2013.

L. Lau, Cytogenetic alterations in renal tumors: a study of 38 Southeast Asian patients, Cancer Genetics and Cytogenetics, vol.175, issue.1, pp.1-7, 2007.
DOI : 10.1016/j.cancergencyto.2007.01.002

V. Lindgren, Cytogenetic Analysis of a Series of 13 Renal Oncocytomas, The Journal of Urology, vol.171, issue.2, pp.602-606, 2004.
DOI : 10.1097/01.ju.0000109172.07081.16

R. Lonser, Von Hippel-Lindau disease, Lancet, Jun, vol.14361, issue.9374, pp.2059-67, 2003.

A. Lopez-beltran, 2004 WHO Classification of the Renal Tumors of the Adults, European Urology, vol.49, issue.5, pp.798-805, 2004.
DOI : 10.1016/j.eururo.2005.11.035

B. Mian, PROGNOSTIC FACTORS AND SURVIVAL OF PATIENTS WITH SARCOMATOID RENAL CELL CARCINOMA, The Journal of Urology, vol.167, issue.1, pp.65-70, 2002.
DOI : 10.1016/S0022-5347(05)65384-0

P. Meyer, Xp11.2 Translocation Renal Cell Carcinoma With Very Aggressive Course in Five Adults, American Journal of Clinical Pathology, vol.128, issue.1, pp.70-79, 2007.
DOI : 10.1309/LR5G1VMXPY3G0CUK

H. Oda, Mutations of P53 gene and P53 protein expression are associated with sarcomatoid transformation in renal cell carcinoma, Cancer Res, vol.55, pp.658-62, 1995.

A. Ooi and K. Furge, Fumarate hydratase inactivation in renal tumors: HIF1 alpha, NRF2, and "cryptic targets" of transcription factors, Chinese Journal of Cancer, vol.31, issue.9, pp.413-433, 2012.
DOI : 10.5732/cjc.012.10102

J. Patard, Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma, International Journal of Cancer, vol.98, issue.2, pp.395-400, 2008.
DOI : 10.1002/ijc.23496

URL : https://hal.archives-ouvertes.fr/hal-00278587

G. Palmedo, Fluorescent microsatellite analysis reveals duplication of specific chromosomal regions in papillary renal cell tumors, Lab Invest, vol.77, pp.633-641, 1997.

G. Palmedo, Duplications of DNA sequences between loci D20S478 and D20S206 at 20q11.2 and between loci D20S902 and D20S480 at 20q13.2 mark new tumor genes in papillary renal cell carcinoma, Lab Invest, vol.79, pp.311-317, 1999.

G. Pignot, Survival Analysis of 130 Patients with Papillary Renal Cell Carcinoma: Prognostic Utility of Type 1 and Type 2 Subclassification, Urology, vol.69, issue.2, pp.230-235, 2007.
DOI : 10.1016/j.urology.2006.09.052

A. Sandberg, The Chromosomes in Human Cancer and Leukemia, 1990.

M. Sanders, Unique Patterns of Allelic Imbalance Distinguish Type 1 from Type 2 Sporadic Papillary Renal Cell Carcinoma, The American Journal of Pathology, vol.161, issue.3, pp.997-1005, 2002.
DOI : 10.1016/S0002-9440(10)64260-5

J. Sandlund, Prognostic impact of carbonic anhydrase IX expression in human renal cell carcinoma, BJU International, vol.9, issue.3, pp.556-560, 2007.
DOI : 10.1159/000102980

J. Sanjmyatav, Comparative study of renal cell carcinoma by CGH, multicolor-FISH and conventional cytogenic banding analysis, Oncology Reports, vol.14, pp.1183-1190, 2005.
DOI : 10.3892/or.14.5.1183

C. Schleicher, Gain of Chromosome 8q: A Potential Prognostic Marker in Resectable Adenocarcinoma of the Pancreas?, Annals of Surgical Oncology, vol.74, issue.Suppl 1, pp.1327-1335, 2007.
DOI : 10.1245/s10434-006-9113-x

T. Shimazui, Decreased expression of ??-catenin is associated with poor prognosis of patients with localized renal cell carcinoma, International Journal of Cancer, vol.72, issue.5, pp.523-528, 1997.
DOI : 10.1002/(SICI)1097-0215(19971021)74:5<523::AID-IJC8>3.0.CO;2-5

M. Schoenberg, Frequent Loss of Chromosome Arms 8p and 13q in Collecting Duct Carcinoma (CDC) of the Kidney, Genes, Chromosomes and Cancer, vol.151, issue.1, pp.76-80, 1995.
DOI : 10.1002/gcc.2870120115

M. Speicher, Specific loss of chromosomes 1, 2, 6, 10, 13, 17, and 21 in chromophobe renal cell carcinomas revealed by comparative genomic hybridization, Am J Pathol, vol.145, pp.356-64, 1994.

G. Steiner, High-density mapping of chromosomal arm 1q in renal collecting duct carcinoma: region of minimal deletion at 1q32.1-32.2, Cancer Res, vol.56, pp.5044-5050, 1996.

M. Tsuda, TFE3 Fusions Activate MET Signaling by Transcriptional Up-regulation, Defining Another Class of Tumors as Candidates for Therapeutic MET Inhibition, Cancer Research, vol.67, issue.3, pp.919-948, 2007.
DOI : 10.1158/0008-5472.CAN-06-2855

R. Weber, Characterization of Genomic Alterations in Hepatoblastomas, The American Journal of Pathology, vol.157, issue.2, pp.571-578, 2000.
DOI : 10.1016/S0002-9440(10)64567-1

B. Wondergem, Expression of the PTTG1 Oncogene Is Associated with Aggressive Clear Cell Renal Cell Carcinoma, Cancer Research, vol.72, issue.17, pp.4361-71, 2012.
DOI : 10.1158/0008-5472.CAN-11-2330

M. Yao, VHL Tumor Suppressor Gene Alterations Associated With Good Prognosis in Sporadic Clear-Cell Renal Carcinoma, CancerSpectrum Knowledge Environment, vol.94, issue.20, pp.1569-1575, 2002.
DOI : 10.1093/jnci/94.20.1569

Z. Zhuang, Trisomy 7-harbouring non-random duplication of the mutant MET allele in hereditary papillary renal carcinomas, Nature Genetics, vol.20, issue.1, pp.66-75, 1998.
DOI : 10.1038/1727